AirSculpt Technologies, Inc. (AIRS) Fair Value 2026

AIRS · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.1 /10

32 fundamental signals · 3 models active

Value Trap Risk

LOW (28/100)

Quick Summary — As of 2026-08-27, AirSculpt Technologies, Inc. (AIRS) trades at $2.61, versus a $0.23 median fair value across its 3 active models — 91.1% below the current price. QOC: 6.1/10. Value Trap Risk: 28/100 (LOW). 3/13 models active. Within that set, the Bayesian DCF component alone returns $0.23.

Key Facts

Ticker
AIRS
Price
$2.61
Quality Score
6.1/10
Value Trap Risk
28/100
Models Active
3/13
Last Updated
Strength: 3 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is AirSculpt Technologies, Inc. (AIRS) Undervalued or Overvalued in 2026?

According to CirclFi’s 3-model valuation engine, AirSculpt Technologies, Inc. (AIRS) appears overvalued as of : the median of 3 independent fair value estimates is $0.23, 91.1% below the current price of $2.61. Estimates range from $0.21 to $2.19. AIRS scores 6.1/10 on fundamental quality and 28/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. AIRS’s -91.1% gap is wider than that market norm, and the Medical Care Facilities sector median is -28.6%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy AirSculpt Technologies, Inc. Stock in 2026? →

What Fair Value Does Each Model Give AIRS?

3 Intrinsic Value Models vs. Current Price ($2.61)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $0.23 -91.1%
Intrinsic · High Conviction
 $0.21 -92.1%
Option-Based · Medium Conviction
 $2.19 -16.1%

All Models Active

All 3 models are displayed above.

What Is AIRS's Fair Value Range?

Spread across 3 independent models · $0.21 to $2.19

CirclFi's 3 active models place AirSculpt Technologies, Inc. (AIRS) between $0.21 and $2.19 per share, a spread of 850% of the median. The median of that range — $0.23 — is the fair value CirclFi publishes for AIRS, against a current price of $2.61.

Low · RCMH-DCFHigh · PWERM
$0.21median $0.23$2.19
Where the range comes from
Most bearish modelRCMH-DCF$0.21
Most bullish modelPWERM$2.19
Model agreement0 bullish · 3 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for AIRS. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on AIRS, not a CirclFi price target. How each model works →

What Is AirSculpt Technologies, Inc. (AIRS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, AirSculpt Technologies, Inc.'s intrinsic value is estimated at $0.23, suggesting the stock is overvalued at its current price of $2.61. With 3 out of 3 models flagging downside (-91.1% vs price), the market may be pricing in unsustainable growth. The most optimistic model, PWERM, places fair value at $2.19 (-16.1%), while RCMH-DCF — the most conservative — estimates $0.21 (-92.1%). This +76.0% gap reflects genuine analytical uncertainty about AirSculpt Technologies, Inc.'s intrinsic worth.

What Do the Models Say About AIRS?

3 of 13 models are currently active for AIRS. All 3 active models suggest the stock trades above fair value. Taken together, their median fair value for AIRS is $0.23 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $0.23 on its own, implying -91.1% downside from the current price. See which stocks rank higher →

How Does AIRS Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, AIRS ranks #35 by Quality of Company score. CirclFi's QOC score of 6.1/10 evaluates 32 fundamental signals. A score of 6.1 indicates above-average quality.

See all Most Undervalued Medical Care Facilities Stocks →

AirSculpt Technologies, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is AIRS a Value Trap?

CirclFi's Value Trap algorithm assigns AIRS a score of 28/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

3 of 13 models are active for AirSculpt Technologies, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, AirSculpt Technologies, Inc. is rated at 6.1/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +76.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AIRS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across AIRS's 3 active models, average confidence is 49%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy AirSculpt Technologies, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

RHEPRegional Health Properties, Inc.QOC 6.2MCTACharming Medical LimitedQOC 6.1SGRYSurgery Partners, Inc.QOC 6.4CCMConcord Medical Services Holdings LimitedQOC 6.1SRTAStrata Critical Medical, Inc.QOC 6.5SYRASyra Health Corp.QOC 5.9BICXBioCorRx Inc.QOC 4.9ENSGThe Ensign Group, Inc.QOC 8.5CONConcentra Group Holdings Parent, Inc.QOC 7.5ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: RHEP · MCTA · SGRY · CCM · SRTA · SYRA · BICX · ENSG · CON · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to AIRS?

7 companies across all industries closest to AIRS’s Quality of Company score of 6.1/10.

LOCLLocal Bounti CorporationQOC 6.1LWLGLightwave Logic, Inc.QOC 6.1TXOTXO Partners, L.P.QOC 6.1BHBiglari Holdings Inc.QOC 6.1CCThe Chemours CompanyQOC 6.1IBRXImmunityBio, Inc.QOC 6.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LOCL · LWLG · TXO · BH · CC · IBRX · NVDA

Where Does AIRS Sit in CirclFi's Medical Care Facilities Rankings?

AIRS is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About AirSculpt Technologies, Inc.’s Valuation?

What is AirSculpt Technologies, Inc.'s intrinsic value in 2026?

CirclFi puts AirSculpt Technologies, Inc. (AIRS)'s intrinsic value at $0.23 — the median of 3 independent model estimates as of 2026-08-27, ranging from $0.21 to $2.19. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $0.23 on its own. The Quality of Company score is 6.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AIRS overvalued or undervalued right now?

At $2.61, 0 of 3 active models suggest AIRS may be undervalued, while 3 indicate potential overvaluation. The median of all 3 fair value estimates is $0.23, 91.1% below the current price of $2.61 — a consensus view that AIRS is overvalued. The assessment depends on which methodology best fits AirSculpt Technologies, Inc.'s business model in Medical Care Facilities.

What does a Quality of Company score of 6.1 mean for AIRS?

AirSculpt Technologies, Inc.'s QOC of 6.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on AIRS?

CirclFi analyzes AIRS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 3 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on AIRS?

Of the 3 models currently active on AIRS, PWERM is the most bullish at $2.19 per share, and RCMH-DCF is the most bearish at $0.21. CirclFi's published fair value for AIRS is the median of that range, $0.23, not either extreme. The gap between the two ends equals 850% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is AIRS a value trap in 2026?

AirSculpt Technologies, Inc.'s Value Trap score is 28/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 3-model valuation engine, AirSculpt Technologies, Inc. (AIRS) has a median fair value of $0.23 — 91.1% below the current price of $2.61 — as of 2026-08-27.” Source: circlfi.com/stock/AIRS/ · Methodology
Primary sources for this AIRS valuation
  • Financial statements: AirSculpt Technologies, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001870940) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for AIRS as of ; valuations recomputed .